Patient selection for percutaneous mitral valve repair: insight from early clinical trial applications.

摘要: Surgical valve repair for mitral regurgitation (MR) has been used decades. Percutaneous approaches to have undergoing evaluation in trials over the last few years, and could offer less-invasive alternatives surgery treatment of MR. Patient selection surgical defined not only by pathophysiology MR, but also likelihood successful degenerative compared with functional Patients MR excellent acute long-term results following repair; risks patients heart failure are high comparison, late recurrent problematic after ischemic percutaneous will be influenced both underlying pathology expected outcomes various patient subsets, characteristics devices. This Review examines established criteria discusses potential impact new approaches.